Copyright © 2026 A&T Respiratory Lectures All Rights Reserved
By Terrence Shenfield MS, RRT-ACCS, RPFT, RPFT, NPS, AE-C
Bronchopulmonary Dysplasia (BPD) is a chronic lung disease that predominantly affects premature infants with low birth weight or those who have required mechanical ventilation. It is one of the most concerning complications in neonatal intensive care units (NICUs) worldwide. Understanding its causes, symptoms, prevention, and treatment is critical to improving infant outcomes and mitigating long-term complications.
This article takes a deep look at BPD, offering insights into its underlying causes, signs, steps to prevent the condition, and effective approaches to Bronchopulmonary Dysplasia (BPD) treatment. Whether you’re a respiratory therapist specializing in neonatal care or a parent seeking clarity, this resource will guide you through essential knowledge about BPD.
For more technical educational resources, check out A&T’s Neonatal and Pediatric-focused lectures here.
Bronchopulmonary Dysplasia occurs due to injury to a premature infant’s lungs, often exacerbated by prolonged oxygen therapy or mechanical ventilation. Infants born before 32 weeks of gestation are particularly susceptible as their lungs are underdeveloped, leading to a higher risk of oxygen toxicity and inflammation.
BPD typically develops within the first four weeks after birth and can result in long-term respiratory challenges, requiring comprehensive medical management.
Understanding Bronchopulmonary Dysplasia causes begins with identifying the risk factors associated with preterm infants. While the full etiology is multifactorial, the primary factors include:
Early detection of these causes is crucial for implementing preventative measures in affected infants.
Recognizing Bronchopulmonary Dysplasia symptoms is essential for initiating timely treatments. Infants with BPD may exhibit the following signs:
Healthcare professionals should frequently monitor premature infants in the NICU to detect any symptoms early and avoid progression to severe stages of the disease.
While BPD is a complex condition, several preventative strategies have shown promise in reducing its prevalence and severity in preterm infants. Here are some evidence-based approaches aimed at preventing Bronchopulmonary Dysplasia in infants:
Using non-invasive ventilation methods, such as Continuous Positive Airway Pressure (CPAP), is a primary approach to reducing lung injury caused by mechanical ventilators. Modern NICUs emphasize early extubation whenever feasible.
Maintaining targeted oxygen saturation levels decreases the risk of oxygen-induced lung damage. Healthcare teams employ strict protocols to avoid hyperoxia while ensuring adequate oxygen delivery to meet the infant’s metabolic demands.
Exogenous surfactant replacement has revolutionized neonatal respiratory care. Early administration of surfactants can improve gas exchange and reduce the likelihood of ventilator dependence.
Adhering to stringent infection control measures within NICUs, coupled with timely administration of antibiotics, minimizes the risk of infections that can lead to lung inflammation.
Improving maternal health prior to delivery can significantly lower the risk of preterm births. Administering corticosteroids like betamethasone to pregnant women at risk of delivering prematurely helps accelerate fetal lung maturity.
Once BPD is diagnosed, the focus shifts to implementing a multidisciplinary management plan tailored to the infant’s unique needs. Effective Bronchopulmonary Dysplasia treatment combines respiratory support, medication, and nutritional optimization.
For many infants with BPD, supplemental oxygen remains a vital part of treatment. Some may require continued use of CPAP or high-flow nasal cannula therapy to maintain proper gas exchange.
Mechanical ventilation is reserved for more severe cases, but the goal remains non-invasive interventions whenever possible.
Preterm infants with BPD require carefully managed nutrition to meet their increased energy demands. Adequate caloric intake, delivered through fortified breast milk or specialized formulas, supports lung growth and overall development.
Infants diagnosed with BPD require comprehensive follow-up care, including routine pulmonary assessments and developmental monitoring. Early intervention services and respiratory therapy are critical to improving long-term outcomes.
For in-depth details and approaches, consult A&T Respiratory Lectures’ Neonatal and Pediatric resources.
Research continues to explore innovative treatments for BPD. Among the promising developments are stem cell therapies, which aim to repair damaged lung tissue, and advanced biomarkers for early disease detection.
Addressing the needs of infants with BPD requires collaboration among physicians, respiratory therapists, nurses, and dietitians. The interdisciplinary approach ensures that all aspects of the infant’s care are optimized—from respiratory therapy to nutritional plans.
Family-centered care is also vital. Parents are integral to the treatment process, providing emotional support and participating in decision-making throughout their infant’s NICU stay and beyond.
For parents, navigating the complexities of BPD can be overwhelming. Providing accessible education about the condition, ongoing treatments, and developmental expectations empowers families to take an active role in their child’s care.
Healthcare providers can explore training opportunities and advanced resources by visiting A&T Respiratory Lectures’ educational platform.
Healthcare professionals dedicated to neonatal care play a pivotal role in advancing treatment protocols and supporting impacted families.
To further enhance your understanding of BPD and therapeutic strategies, explore A&T Respiratory Lectures’ full resource collection here.
Respiratory care changes fast. At A&T Respiratory Lectures, we want to help you stay ahead.
Our articles are great for everyone. Experienced therapists use them to improve patient care. Newcomers use them to grow their careers. We provide the tools you need to succeed.